YAP inhibitor JUN: New findings on liver cancer
Research project funded by the Wilhelm Sander Foundation successfully completed: Researchers led by Dr Björn von Eyss at the Leibniz Institute for Ageing Research – Fritz Lipmann Institute (FLI) have discovered a surprising protective function of the JUN gene. JUN, previously known as an enhancer of inflammatory and growth signals, has the opposite effect in certain situations. In such cases, it acts as a cellular safety mechanism. If the growth protein YAP becomes too active, JUN curbs its activity. In this way, JUN prevents uncontrolled cell growth and cell proliferation. This protective mechanism could help curb the development of tumours, particularly liver cancer.
A boost for cancer research: The Wilhelm Sander Foundation is funding 15 research projects in the third quarter of 2025 with 2.6 million euros
The Wilhelm Sander Foundation is supporting 15 promising research projects across various fields of oncology with total funding of 2,601,092 euros. Through its funding, the Foundation enables researchers to explore innovative approaches to combating cancer: from the use of artificial intelligence in early detection to new immunotherapy approaches.
Wilhelm Sander Foundation receives 414,000 euros for medical research
The Wilhelm Sander Foundation has received a generous donation of 414,000 euros from the German Research Foundation (DFG), funded by the Georg Thieme Memorial Foundation. The grant will be used to support innovative research projects and thus contributes directly to the Foundation’s central aim of facilitating scientific progress, particularly in medical research.